
Dr. Irfan Dhalla, who has studied the opioid-addiction problem, is skeptical about Purdue Pharma’s marketing claims that switching from OxyContin to OxyNEO will result in fewer misuse and abuses of the potentially lethal drugs.










Copyright 2013 Grind365